← All stocks

HERON THERAPEUTICS, INC. /DE/

HRTX No buying or selling

CIK 0000818033 #4644 in the set updated 21 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

12 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Rubric Capital Management LP entity

10% owner

—

30,046,828

15.83%

$45.07M

+12.5%

Morgan Adam

Director

—

8,877,027

4.68%

$13.32M

+26.1%

Collard Craig A

Chief Executive Officer

—

856,492

0.4511%

$1.28M

+174.2%

Duarte Ira

EVP, Chief Financial Officer

—

281,899

0.1485%

$422.85K

+100.6%

Forbes William P

EVP, Chief Development Officer

—

241,173

0.1270%

$361.76K

+143.0%

Hensley Mark Earl

Chief Operating Officer

—

170,901

0.0900%

$256.35K

—

Rodriguez Susan

Director

—

87,180

0.0459%

$130.77K

+25.9%

Kaseta Michael

Director

—

53,960

0.0284%

$80.94K

—

Johnson Craig A

Director

—

53,960

0.0284%

$80.94K

—

Christian Waage

Director

—

53,960

0.0284%

$80.94K

—

Cusack Thomas

Director

—

53,960

0.0284%

$80.94K

—

Dissanaike Sharmila

Director

—

53,960

0.0284%

$80.94K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 43

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 1

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 2,073,066

History held since 7 Oct 2016